Mingli Li, Ph.D.

626-218-2975
Mingli Li, Ph.D.
Postdoctoral Fellow, Department of Systems Biology
Research Area
  • Molecular Cell Biology and Biochemistry in Cancer Research
  • Drug Discovery Using Cell Based Disease Model Screening
  • Identification of Novel Therapeutic Targets to Eliminate Cancer Cells
Academic Appointments

Postdoctoral Fellow, Department of Systems Biology

Mingli Li completed her PhD from University of Birmingham, United Kingdom. Her Ph.D. thesis focused on mechanistic analysis of Apoptosis-induced Proliferation (AiP) and non-apoptotic cell death in Drosophila. In April 2017, she joined Prof. Eric Witze’s laboratory at the University of Pennsylvania (UPENN) as a Postdoctoral Researcher. At UPENN, her research focused on understanding the physiological and pathological roles of palmitoylation, a type of protein post-translational modification. In December 2018, she then joined the laboratory of Chun-Wei (David) Chen in the Department of Systems Biology as a Postdoctoral Fellow. She is interested in identifying novel therapeutic targets for leukemia driven by mixed-lineage leukemia gene rearrangement (MLL-r) using CRISPR screening.
 

Location

Education & Experience

Degrees

  • 2017, Ph.D., Developmental Biology, University of Birmingham, United Kingdom

  • 2013, M.S., Molecular and Cellular Biology, Chinese Academy of Sciences, China

  • 2010, B.S., Biological Sciences, Henan Normal University, China

Professional Experience

  • 2018 – present, Postdoctoral Fellow, Department of Systems Biology, City of Hope, Duarte, CA

  • 2017 – 2018, Postdoctoral Researcher, Department of Cancer Biology, University of Pennsylvania, PA

Awards & Memberships

Awards

  • 2013, University of Birmingham PhD study fee waiver scholarship

  • 2013, China Scholarship Council PhD study living fee scholarship

  • 2011, Excellent Student Leader, Chinese Academy of Sciences

  • 2010, Outstanding Graduates, Henan Normal University

  • 2008 & 2009, National Scholarship for Excellent Students

Memberships

  • 2018 - present, American Association for Cancer Research (AACR)
    2016 - 2017, Genetic Society of American (GSA)
    2015 - 2016, British Society of Development Biology (BSDB)

Publications